In response to an employee survey two years ago that revealed shockingly low morale, IU Health executives respond with 33 town hall meetings over four months.
Over the past 20 years, while the price of a gallon of milk climbed 23 percent and the sticker on a Dodge Caravan minivan rose 21 percent, the list price of the insulin Humalog shot up 1,157 percent.
Naomi Pescovitz, a North Central High School graduate, will help to launch a 7 p.m. newscast at KMSP-Fox 9, which she said will “give me my weekends back and I’ll be able to turn off that 1:30 a.m. alarm clock.”
Danish drugmaker Novo Nordisk says it has reached a settlement over allegations that it hadn’t properly communicated safety information when marketing a medicine to treat type 2 diabetes.
li Lilly and Co.’s experimental breast cancer drug abemaciclib, when combined with standard therapy, slowed the progression of tumors in patients with an advanced form of the disease.
The new “clarifying guidance” from the Centers for Medicare and Medicaid Services could provide a big challenge to new micro hospitals popping up in central Indiana and nationally.
Hoosiers buying health insurance on the Obamacare marketplace will pay an average of nearly $500 a month in premiums next year, a sharp rise over current rates.
Five hundred medical students from IU have received training in Kenya, and lessons learned from the program have been applied back here in the United States.
After struggling for more than 20 years to develop cancer drugs without success, West Lafayette-based Endocyte Inc. is pausing it own R&D efforts to concentrate on a potential blockbuster drug from a German chemical company.
High-deductible health plans are booming in popularity, but, in an effort to save money, too many people are skipping preventive care even though such visits are covered 100 percent.
